IQVIA Holdings Inc

IQVIA Holdings Inc

IQV - NEW YORK STOCK EXCHANGE, INC.

Industry: Life Sciences Tools & Services

Market Cap: 26.5 B

IPO Date: May 9, 2013

Country: US

Currency: USD

Shares Outstanding: 176.3 M

IQVIA: Q1 Earnings Support Steady Optimism

5/9/2025

IQVIA reports strong Q1 earnings with $3.83B revenue & raised guidance.

News

Source: SeekingAlpha

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

5/7/2025

RESEARCH TRIANGLE PARK, N.C., May 07, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Annual Health Care Conference on Tuesday, May 13, 2025, at 5:20 p.m. ET (2:20 p.m. local PT).

News

Source: Yahoo

IQVIA Holdings Inc. stock outperforms competitors on strong trading day

5/7/2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day

News

Source: MarketWatch

IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

5/7/2025

IQVIA Holdings Inc (IQV) reports robust Q1 results with significant growth in Technology and Analytics Solutions, despite challenges in the R&D sector.

News

Source: Yahoo

Q1 2025 IQVIA Holdings Inc Earnings Call

5/7/2025

Q1 2025 IQVIA Holdings Inc Earnings Call

News

Source: Yahoo

IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

5/7/2025

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

News

Source: Yahoo

IQVIA Holdings (NYSE:IQV) Reports US$3,829 Million Sales Q1 2025; Raises Full-Year Revenue Guidance

5/6/2025

IQVIA Holdings (NYSE:IQV) recently announced its first-quarter earnings report, revealing a modest increase in sales but a decline in both net income and earnings per share compared to the previous year. The company also revised its full-year revenue guidance upward due to favorable currency exchange rates. Over the last week, IQV's share price climbed 1.45%, reflecting a somewhat positive response to these developments. Meanwhile, the broader market saw mixed sentiments as the S&P 500 ended...

News

Source: Yahoo

IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors

5/6/2025

IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors

News

Source: MarketWatch

IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y

5/6/2025

IQV's top line in the first quarter of 2025 benefits from the Research and Development, and Technology and Analytics segments.

News

Source: Yahoo

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

5/6/2025

IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ETCompany ParticipantsKerri Joseph - Senior Vice President, Investor...

News

Source: SeekingAlpha

IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic

5/6/2025

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.

News

Source: Yahoo

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

5/6/2025

IQVIA (IQV) delivered earnings and revenue surprises of 2.66% and 1.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

News

Source: Yahoo

IQVIA: Q1 Earnings Snapshot

5/6/2025

On a per-share basis, the Durham, North Carolina-based company said it had net income of $1.40. Earnings, adjusted for one-time gains and costs, came to $2.70 per share. The results surpassed Wall Street expectations.

News

Source: Yahoo

IQVIA Reports First-Quarter 2025 Results

5/6/2025

RESEARCH TRIANGLE PARK, N.C., May 06, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended March 31, 2025.

News

Source: Yahoo

IQVIA beats quarterly profit estimates on higher demand for research services

5/6/2025

Contract research firm IQVIA Holdingsbeat Wall Street estimates for first-quarter profit onTuesday, helped by better-than-expected demand for its drugresearch and development services. ...

News

Source: Finnhub

IQVIA (IQV) Q1 Earnings Report Preview: What To Look For

5/5/2025

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect.

News

Source: Yahoo

After an up and down year, pharma’s R&D landscape is shifting again

5/5/2025

While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.

News

Source: Yahoo

IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors

5/1/2025

IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors

News

Source: MarketWatch

IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock?

5/1/2025

Growth across the R&DS and TAS segments is anticipated to have boosted IQV's top line in the first quarter of 2025.

News

Source: Yahoo

IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

5/1/2025

Evaluate the expected performance of IQVIA (IQV) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

News

Source: Yahoo